Amit Noam, Market Development @ RISE, an innovation group of Teva. Amit has an entrepreneurial and strategic consulting background. Prior to joining Teva, Amit was a team leader at Shaldor, an Israeli strategic consultancy. Amit Holds a B.Sc in Industrial engineering and an EMBA from TAU University.
Assaf Barnea, CEO of Sanara VC is a seasoned entrepreneur and venture professional with multidisciplinary experience in innovation and commercialization in healthcare. Mr Barnes serves also as the Chairman of the life science advisory board at the Israeli export institute
Avinoam Sapir, CEO of Teva Israel and Region SVP (Africa, Middle East, Ukraine and India). Avinoam held executive positions in Teva (CEO of SLE, VP BD at Teva's Headquarters). Avinoam holds a BA (Summa Cum Laude) in Economics and Logistics from Bar Ilan University and an MBA from Tel Aviv University.
Aviva Levin, Market Insight Director, Growth Markets, Respiratory and new TAs. Wide experience in marketing specialty medicine in a variety of TAs. Lead the Branded Rx business of Teva Israel including the local in licensing and BD activity of the innovative Rx medicines
Enrique Villarreal, COO in Teva Mexico, has lead Pharma Companies for over 20 years. He currently heads the Medical, Innovation, Business Development, and Portfolio Management departments. Enrique is passionate about innovation and a natural enabler. He holds an MBA from Thunderbird University.
Eran Gefen, seasoned med-tech executive and physician with more than 12 years of experience at Teva, Merck (MSD), Schering-Plough and MetaCure in Medical Affairs, product launch, clinical strategy, pre-commercial evaluations, evidence generation and BD.
Eran Toledo, CTO of Sanara VC is an experienced executive, with strong background in both academic research and industrial development projects. He holds a BSc degree in Physics and Mathematics from the Hebrew University and a PhD in Medical Physics from Tel Aviv University.
Erdem Güleç, Medical Manager in Teva-Turkey specialized in multiple therapeutic areas. Interested in innovation in movement disorders especially for Parkinson's disease. Before joining Teva, Dr. Güleç worked in Emergency department.
Funda Koc, Sr. Medical Manager in Turkey, responsible for movement disorders and respiratory drugs, business development and marketing. Dr. Koc has wide experience in specialty medicine (Novo Nordisk and Sanofi).
Hasan Akçiçek, Sr. Medical Manager for Wake, Psychiatry and Migraine therapeutic areas in Teva-Turkey. Before joining Teva, he worked in medical affairs department in other pharmaceutical companies (Abdi İbrahim Pharmaceuticals, Novartis). Graduated from University of Aydın, Adnan Menderes.
Neta Zach, Director and head of Academic Affairs at Teva global R&D. Before joining Teva she served as Chief Scientific Officer at Prize4Life. Prior to that she was a faculty member at U. Pennsylvania. She holds a Ph.D. in Neuroscience from the Hebrew University and an MPA from U. Pennsylvania.
Ronen Tamir, SVP Solution Architecture and Integration, in Teva’s. Prior joining Teva, Ronen worked at GE Healthcare and other leading companies in the pharmaceutical and Diagnostics industry. Ronen holds a B.Sc in Biology from Bar-Ilan University, and MBA from Warwick Business School in the UK
Managing Director of RISE at Teva. Co-founder & board member of Sanara Ventures, Healthcare Innovation Launchpad JV of Teva and Philips. Bringing 15 year experience in Strategy, Innovation & Business Development, serving as VP at top-tier strategy consultancy and leading entrepreneurial ventures.
Sharon Fireman, Crowd innovation Manager of RISE. Sharon, crowd expert, initiated and led a successful crowdsourcing project in Teva's global generic R&D. Prior to that, she held various management roles in specialty and generic R&D. Sharon holds Ph.D. in Chemistry and MBA from Tel-Aviv University
Tatyana Gorokhova, Medical Director for Multiple sclerosis and Migraine in Teva, Growth markets region. Experienced in medical affairs in ethical pharma companies. Dr. Gorokhova graduate cum laude from Russian State Medical University, a certified endocrinologist with Ph.D. in endocrinology.
Yossi Ofek, Managing Director of the Pharma – Innovative Solutions Business in Teva Israel. In the last 20 years, Yossi held various senior roles in Teva. Yossi is on the board directors in a number of private companies, Teva Medical, Rhenium and Sanara VC. Yossi holds an MBA from Derby University.